Schedule a Meeting
1. Marketing Research Bureau. The plasma proteins market in the United States—2018. Revised 2019:1-298.
Explore the only approved Ig therapy for people living with MMN.
Explore all of our approved Ig therapies for people living with PI.
This site is intended for US residents and governed by US laws and government regulations.
©2022 Takeda Pharmaceuticals U.S.A.,
Lexington, MA 02421. 1-877-TAKEDA-7.
All rights reserved. OnePath is a trademark or registered trademark of Shire, a Takeda company. CUVITRU, HYQVIA, Gammagard and MYIGSOURCE are trademarks or
registered trademarks of Baxalta Incorporated, a Takeda company. Takeda and the Takeda logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.
The information on this website has been specifically created for US healthcare professionals (HCPs).